Most people walk out of their GP surgery with an HbA1c below 5.7% and feel quietly relieved. Normal. Nothing to worry about. Carry on. And for the majority, that reassurance is entirely reasonable. But here is something that rarely makes it into that five-minute appointment, not all “normal” results carry the same metabolic weight. Specifically, if your HbA1c sits between 5.0% and 5.4%, the science suggests you are in genuinely good territory. Below 5.0%, however, or nudging closer to 5.6%, the picture becomes more nuanced, and more worth paying attention to, than most people realize.
So, what actually counts as “optimal”, and when should you start paying closer attention?
What the Research Actually Says About the 5.0% to 5.4% Range
The idea that lower is always better with HbA1c is one of the most persistent misconceptions in metabolic health. A large-scale analysis published in JAMA Internal Medicine, drawing on data from over 45,000 adults, found that all-cause mortality and cardiovascular event rates were lowest in individuals with HbA1c sitting between 5.0% and 5.4%. This was not a marginal finding tucked away in a footnote; it was a consistent pattern across age groups and both sexes. The researchers noted that risk began climbing meaningfully once HbA1c moved in either direction from this window, whether upward toward prediabetes or downward toward the sub 5.0% range.
Risk began to rise outside this window, particularly toward prediabetes levels, while very low HbA1c values (<5.0%) have also been associated with higher mortality in some studies, though this may reflect underlying health conditions rather than glucose control itself.
What this tells us, practically speaking, is that the 5.0% to 5.4% band reflects a metabolic state where blood glucose is neither too high nor too low, insulin sensitivity is likely well preserved, and the pancreatic beta cells, the cells responsible for producing insulin, are not under significant strain. It is, in the most straightforward terms, where your body’s glucose handling machinery appears to run most efficiently.
Insulin Resistance (The Risk That Hides in Plain Sight)
Here is the uncomfortable truth about the upper end of the normal range. Someone with an HbA1c of 5.5% or 5.6% is still technically normal by clinical definitions, but emerging research suggests that insulin resistance, the root driver of type 2 diabetes and a major contributor to cardiovascular disease, can be well established long before HbA1c crosses the 5.7% prediabetes threshold.
A 2021 study published in Diabetes & Metabolism found that insulin resistance, measured via HOMA-IR, was significantly elevated in individuals with HbA1c between 5.5% and 5.6% compared to those sitting at 5.0% to 5.2%, despite both groups falling within the conventional normal range. The pancreas, in these cases, was already working harder than it should to maintain what looked on paper like normal glucose levels. This compensatory hyperinsulinemia is clinically silent, you will not feel it, but it matters enormously for long-term cardiovascular and metabolic risk.
Cardiovascular Risk Starts Earlier Than Most People Think
The relationship between HbA1c and cardiovascular risk does not switch on at 5.7%. It exists on a continuous gradient. A meta-analysis published in The Lancet in 2010, involving over 300,000 participants without a prior diabetes diagnosis, demonstrated a progressive association between higher HbA1c, even within the normal range. and increased risk of coronary heart disease and stroke. Individuals at 5.5% to 5.6% carried measurably higher cardiovascular risk than those at 5.0% to 5.2%, independent of traditional risk factors such as smoking, blood pressure, and cholesterol.
From a pharmacist’s perspective, this is the kind of data that reframes the conversation entirely. It is not about crossing a diagnostic threshold, it is about trajectory. Where is your HbA1c heading, and what is your wider metabolic picture telling you alongside it?
What Else Should Be on Your Radar Alongside HbA1c?
HbA1c does not exist in isolation, and if you are sitting in the 5.0% to 5.6% range and want to assess your true metabolic risk, there are several other markers worth discussing with your GP or pharmacist.
Fasting Insulin
Fasting insulin is arguably the most underused tool in routine metabolic screening. Because HbA1c can appear normal while insulin levels are already elevated, fasting insulin gives a far earlier signal of insulin resistance. A raised fasting insulin, even with a normal HbA1c, tells you the pancreas is compensating, and that compensation has a shelf life.
Triglyceride to HDL Ratio
High triglyceride levels alongside low HDL cholesterol form one of the most reliable proxy markers for insulin resistance in clinical practice. A 2020 paper in Cardiovascular Diabetology identified the triglyceride to HDL ratio as a stronger predictor of incident type 2 diabetes than HbA1c alone in non-diabetic populations. If your triglycerides are consistently above 1.7 mmol/L and your HDL is low, that combination warrants attention regardless of where your HbA1c sits.
Waist Circumference
Visceral adiposity, fat stored around the abdominal organs rather than just under the skin. is strongly associated with insulin resistance, elevated inflammatory markers, and metabolic syndrome, all of which can coexist quietly with a perfectly normal HbA1c. NICE guidance recognizes waist circumference as an independent risk factor for type 2 diabetes and cardiovascular disease. For men, a waist above 94 cm raises risk; above 102 cm, it is high. For women, the thresholds are 80 cm and 88 cm respectively.
In South Asian populations, these thresholds are lower still, reflecting a well-documented tendency toward central adiposity at lower body weights.
The Lifestyle Levers That Protect the 5.0% to 5.4% Range
If your HbA1c currently sits in this optimal band, the goal is not to become complacent, it is to understand what is keeping you there and protect it deliberately. The evidence base here is robust and consistent.
Dietary fiber remains one of the most powerfully supported nutritional interventions for glycemic regulation. A 2021 meta-analysis in Nutrients found that higher fiber intake was independently associated with lower HbA1c across multiple population groups. Resistance exercise, not just cardio, has been shown in multiple randomized controlled trials to improve insulin sensitivity by increasing glucose uptake in skeletal muscle, directly reducing the glycemic burden on the pancreas.
And emerging research on sleep quality continues to reinforce what many patients are surprised to hear, poor sleep raises cortisol and disrupts glucose metabolism in ways that accumulate over weeks and months, eventually showing up in your HbA1c results whether you connect the dots or not.
The Bottom Line
An HbA1c between 5.0% and 5.4% is where the evidence points as genuinely optimal, not just acceptable. If you are sitting in this range, that is meaningful and worth maintaining. If you are nudging toward 5.5% or 5.6%, the clinical picture is more layered than a single normal result suggests, and a broader metabolic review is a worthwhile conversation to have.
If your HbA1c is creeping toward 5.5% or higher, consider asking for fasting insulin and a full lipid profile at your next checkup.
Blood sugar health is not a switch that flips at a diagnostic threshold. It is a spectrum, and understanding where you sit on it, and what surrounds that number, is how you stay ahead of it.
FAQs
Q1. Is an HbA1c between 5.0% and 5.4% really the safest range?
Based on current evidence, yes, Research published in JAMA Internal Medicine found that cardiovascular and all-cause mortality risk was lowest in individuals with HbA1c sitting within this window. It is not just about avoiding diabetes; it is about optimizing your broader metabolic health for the long term.
Q2. Can I have insulin resistance with a normal HbA1c?
Absolutely, and this is one of the most important points in this article. Insulin resistance can be well established before HbA1c ever crosses the 5.7% prediabetes threshold. If your HbA1c is sitting at 5.5% or 5.6%, your pancreas may already be working harder than it should. Fasting insulin testing gives a much earlier picture of what is actually happening.
Q3. What is a healthy triglyceride-to-HDL ratio?
A triglyceride to HDL ratio below 1.0 mmol/L is generally considered favorable. A ratio above 2.0 is associated with significant insulin resistance risk. If your triglycerides are consistently elevated and your HDL is low, that combination deserves clinical attention regardless of your HbA1c result.
Q4. What waist measurement should I be concerned about?
For men, a waist circumference above 94 cm raises metabolic risk, and above 102 cm is considered high risk. For women, the thresholds are 80 cm and 88 cm respectively. If you are of South Asian heritage, these thresholds are lower, so it is worth discussing your individual risk with your GP.
Q5. Does poor sleep really affect HbA1c?
Yes, and the evidence is consistent. Poor sleep elevates cortisol, which directly raises blood glucose. Over weeks and months, this disruption accumulates and will eventually be reflected in your HbA1c. Sleep is not a lifestyle luxury, it is a metabolic necessity.
Q6. What should I ask my GP if I am concerned about my metabolic risk?
Ask for a fasting insulin test, a full lipid profile including triglycerides and HDL, and a waist circumference measurement alongside your routine HbA1c. Together, these give a far more complete picture of your metabolic health than HbA1c alone.
Call to Action
A normal HbA1c is a good starting point, but it is only part of the story.
Understanding what sits alongside that number is how you stay genuinely ahead of metabolic risk, not just within a reference range. At PharmaHealths, our content is built on the same evidence your clinician relies on, written in a way that actually makes sense. Explore our full metabolic health series for more, or share this article with someone whose health deserves a closer look than a single test result can offer.
Disclaimer
This article is intended for informational and educational purposes only and does not constitute medical advice. Metabolic risk assessment should always be carried out in the context of your individual health history by a qualified healthcare professional. If you have concerns about your HbA1c, insulin resistance, or cardiovascular risk, please speak to your GP or pharmacist.
References
• Selvin E et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. JAMA Internal Medicine, 2010.
• Emerging Risk Factors Collaboration. Diabetes mellitus, fasting glucose, and risk of cause-specific death. The Lancet, 2010.
• Twig G et al. HbA1c prediabetes and the onset of cardiovascular disease and diabetes. Diabetes & Metabolism, 2021.
• Boivin A et al. Triglyceride to HDL ratio as a predictor of type 2 diabetes in non-diabetic populations. Cardiovascular Diabetology, 2020.
• Reynolds AN et al. Dietary fiber and whole grains in diabetes management. Nutrients, 2021.
• National Institute for Health and Care Excellence. Obesity: identification, assessment and management. NICE Guideline CG189, updated 2023.
• American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care, 2023.
